We are live on ! Find out more
NKGNW

NKGen Biotech, Inc. Warrants
NKGNW

Delisted

NKGNW was delisted on the 4th of March, 2025.

Back to rankings

35 hedge funds and large institutions have $551K invested in NKGen Biotech, Inc. Warrants in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

162% more call options, than puts

Call options by funds: $34K | Put options by funds: $13K

39% more capital invested

Capital invested by funds: $397K → $551K (+$154K)

5% less funds holding

Funds holding: 37 → 35 (-2)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

Holders
35
Holders Change
-2
Holders Change %
-5.41%
% of All Funds
0.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
3
Closed
4
Calls
$34K
Puts
$13K
Net Calls
+$21K
Net Calls Change
-$4K

Top Buyers

Rank Fund Capital Flow
1
CL
CSS LLC
Illinois
+$6.61K
2
ETH
Exos TFP Holdings
New York
+$1.05K
3
FTUS
Flow Traders U.S.
New York
+$192

Top Sellers

Rank Fund Capital Flow
1
DCM
Difesa Capital Management
New York
-$16.9K
2
SCM
Shaolin Capital Management
Florida
-$11.6K
3
CH
CVI Holdings
Delaware
-$3.7K
4
SG
StoneX Group
New York
-$2.07K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$415
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
Rivernorth Capital Management
Florida
$124K -$28 -162 -0%
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$36.4K – – –
Balyasny Asset Management
3
Balyasny Asset Management
Illinois
$31.9K – – –
BNP Paribas Financial Markets
4
BNP Paribas Financial Markets
France
$31.4K – – –
AA
5
AQR Arbitrage
Connecticut
$25.6K – – –
RCM
6
Radcliffe Capital Management
Pennsylvania
$25.1K – – –
PC
7
Periscope Capital
Ontario, Canada
$25K – – –
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
8
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$22.8K – – –
KL
9
KIM LLC
Kansas
$21K – – –
Jane Street
10
Jane Street
New York
$20K – – –
6CM
11
683 Capital Management
New York
$20K – – –
KC
12
Kepos Capital
New York
$17K +$14.1K +80,000 New
PSAMP
13
P. Schoenfeld Asset Management (PSAM)
New York
$16.8K – – –
ETH
14
Exos TFP Holdings
New York
$14.9K +$1.05K +6,000 +9%
TCA
15
Taconic Capital Advisors
New York
$14K – – –
PAMP
16
Polar Asset Management Partners
Ontario, Canada
$12K – – –
D.E. Shaw & Co
17
D.E. Shaw & Co
New York
$10K – – –
AIMCA
18
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$8K – – –
MTCM
19
Mint Tower Capital Management
Netherlands
$8K – – –
FBCM
20
Fort Baker Capital Management
California
$7.74K – – –
CL
21
CSS LLC
Illinois
$7.52K +$6.61K +37,600 New
JFG
22
Jefferies Financial Group
New York
$7K – – –
SCM
23
Saba Capital Management
New York
$6.52K – – –
ACM
24
Atalaya Capital Management
New York
$6K – – –
SC
25
Sculptor Capital
New York
$4.02K -$18 -100 -0.5%
1
2

NKGNW Hedge Fund Activity: Q2 2023 in Review

35 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in NKGen Biotech, Inc. Warrants (NKGNW) for Q2 2023, worth a combined $551K — up 39% from $397K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of NKGNW and 2 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 2 added.

The largest buyer was CSS LLC, opening a new position worth an estimated $6.61K. The largest seller was Difesa Capital Management, exiting entirely with an estimated $16.9K sold.

  • 35 institutional investors held NKGen Biotech, Inc. Warrants (NKGNW) as of Q2 2023, down from 37 in Q1 2023.
  • Funds reported $551K of NKGen Biotech, Inc. Warrants stock for Q2 2023, up 39% quarter-over-quarter.
  • 2 funds opened new NKGen Biotech, Inc. Warrants positions in Q2 2023 and 4 closed out, a net change of -2 holders.
  • The largest NKGen Biotech, Inc. Warrants buyer in Q2 2023 was CSS LLC, an estimated $6.61K added.
  • The largest NKGen Biotech, Inc. Warrants seller in Q2 2023 was Difesa Capital Management, an estimated $16.9K sold.

Based on aggregated 13F filings for Q2 2023.